Showing results (391-400 of 609) with videos related to
Sort By:
Pageof 61
Journal of Neurology, Neurosurgery, and Psychiatry|August 11, 2017
Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studiesKa Sing P Lai, Celina S Liu, Allison Rau, et al.Journal of Alzheimer'S Disease : JAD|July 20, 2019
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with NabiloneMyuri Ruthirakuhan, Nathan Herrmann, Ana C Andreazza, et al.Brain and Behavior|December 5, 2017
Plasma sphingolipids and depressive symptoms in coronary artery diseaseAdam Dinoff, Mahwesh Saleem, Nathan Herrmann, et al.Plos One|March 14, 2014
Cardiopulmonary fitness correlates with regional cerebral grey matter perfusion and density in men with coronary artery diseaseBradley J MacIntosh, Walter Swardfager, David E Crane, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 23, 2025
Relationship Between Smoking and Psychiatric and Somatic Comorbidities in Older Age Bipolar Disorder: Lien entre le tabagisme et les affections psychiatriques et somatiques concomitantes chez les personnes âgées atteintes de trouble bipolaireMolly Howland, Arushi Mahajan, Peijun Chen, et al.Medical Care|August 4, 2009
The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: quality of care implicationsSusan E Bronskill, Paula A Rochon, Sudeep S Gill, et al.Alzheimer'S Research & Therapy|July 14, 2021
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's diseasePhilippe Desmarais, Andrew F Gao, Krista Lanctôt, et al.Contemporary Clinical Trials Communications|July 25, 2019
Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trialMyuri T Ruthirakuhan, Nathan Herrmann, Damien Gallagher, et al.Journal of Psychosomatic Research|October 25, 2016
Validity of the Center for Epidemiological Studies Depression scale in Type 2 diabetesJasmine Carter, Hugo Cogo-Moreira, Nathan Herrmann, et al.International Psychogeriatrics|October 23, 2012
Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic reviewDallas P Seitz, Sudeep S Gill, Nathan Herrmann, et al.Pageof 61